The European Pharmacopoeia Commission re-evaluates its policy on the development of monographs for finished drug products. The European Pharmacopoeia (Ph.Eur.), which is celebrating its 50th ...
Awareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements. The increased number and complexity of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results